Tehran University of Medical Sciences

education📍 Tehran, Iran
Tehran University of Medical Sciences
2
Alpha-gal Syndrome Publications
1
Alpha-gal Syndrome Researchers

Associated Institutions

Imam Khomeini Hospital
child
Roointan Arash Hospital
related
Roozbeh Hospital
related
Sina Hospital
related
Shariati Hospital
related

Alpha-gal Syndrome Researchers

Publications

Heparin-Induced Anaphylaxis With Cardiac Arrest in a Patient With Alpha-Gal Syndrome: A Case Report.

Khanipour R, Bera RK, Suarez I, Soltani Moghadam A, Mattumpuram J
Cureus •

Alpha-gal syndrome (AGS) is a delayed allergic reaction to red meat linked to bites of various species of ticks around the world, with the common culprits in North America identified as the Ixodes and Lone Star ticks. Most cases are asymptomatic, but some may result in mild allergic reactions or could progress to severe anaphylaxis. This report presents the case of a 64-year-old male with a history of coronary artery disease who presented with chest pain. During his hospitalization, he experienced two episodes of ventricular fibrillation (VF) with successful resuscitation. Following discharge, he continued to experience episodic palpitations, abdominal pain, nausea, vomiting, and diarrhea. An immunologist later diagnosed him with AGS and introduced the possible association of the VF events with a severe hyperacute reaction to intravenous heparin exposure, either in conjunction with or independent of the STEMI the patient was experiencing. His chronic longitudinal symptoms resolved entirely with dietary restrictions, specifically avoiding beef and porcine meat derivative products. This report highlights the importance of considering AGS in patients with unexplained allergic or periprocedural reactions following exposure to mammalian-derived products such as heparin.

Successful desensitization of a patient with cetuximab hypersensitivity: A case report.

Solduzian M, Anvari S, Taghvaye Masoumi H, Shahi F, Jahangard-Rafsanjani Z
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners •

Severe hypersensitivity reaction is a dangerous adverse drug reaction in patients receiving cetuximab. It requires drug discontinuation and medical management. A 48-year-old man, previously diagnosed with metastatic colorectal cancer, was admitted for therapy continuation. During the first infusion of cetuximab, the patient experienced acute signs of hypersensitivity reactions. The treatment team decided to administer cetuximab employing the desensitization protocol. This study reports a severe hypersensitivity reaction to cetuximab in an adult patient with colorectal cancer. This patient was successfully managed with a new safe and rapid desensitization protocol.